Final analysis of overall survival for the Phase III CONFIRM trial: fulvestrant 500 mg versus 250 mgAngelo Di Leo,Guy Jerusalem,Lubos Petruzelka,Roberto Torres,Igor N Bondarenko,Rustem Khasanov,Didier Verhoeven,Jose L Pedrini, Iva Smirnova,Mikhail R Lichinitser, Kelly Pendergrass, Sally Garnett,Yuri Rukazenkov,Miguel A MartinCANCER RESEARCH(2012)引用 19|浏览15暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要